Robert Brookins - Alexium International Insider

Alexium International Group Limited -- Australia Stock  

AUD 0.4  0.01  2.44%

VP of RandD

Dr. Robert Brookins is Vice President Research Development of Alexium International Group Ltd. Dr. Brookins has broad experience in organic synthesis and materials chemistry. He received his PhD from the University of Florida under research advisor John R. Reynolds
  VP Since 2015  Ph.D    
61 8 9384 3160  http://www.alexiuminternational.com
Brookins? graduate work was in the synthesis and characterization of conjugated polyelectrolytes and polymers. Upon completion of his PhD, he worked at the Air Force Research Laboratory at Tyndall AFB where he developed decontamination methods for chemical and biological threats and novel synthetic routes for functional surfaces.

Management Efficiency

The company has return on total asset (ROA) of (50.6) % which means that it has lost $50.6 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (141.04) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 5.57 M in total debt with debt to equity ratio (D/E) of 84.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Alexium International Group Limited has Current Ratio of 2.77 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Entity Summary

Alexium International Group Limited develops and sells chemical solutions for military and commercial applications in Australia and the United States. Alexium International Group Limited (AJX) is traded on Australian Securities Exchange in Australia. It is located in Perth, WA and employs 11 people.

Did you try this?

Run Fund Screener Now
   

Fund Screener

Find activelly-traded funds from around the world traded on over 30 global exchanges
Hide  View All  Next  Launch Fund Screener
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Alexium International Group Limited to your portfolio

Top Management

Alexium International Leadership Team
Dirk Hyning, COO
Craig SmithGander, Director
Craig Metz, Director
Cameron Maitland, Executive
Karen Thurman, Director
Stephen Cheney, Director
Kevin Kye, Executive
Jon Heard, Executive
Robert Brookins, VP, Ph.D
Aaron Krech, CFO
Gavin Rezos, Chairman
Nicholas Clark, CEO, CPA

Stock Performance

Alexium International Performance Indicators